Improving Availability of Intranasal Naloxone

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-65
SponsorHartford Hospital

About this trial

While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the emergency department for opioid overdose. The goal of this study is to compare the impact of different overdose education on naloxone prescription fill rates in opioid users being discharged from our hospital emergency department. You will receive either (a) written education about naloxone through their MyChart account, or (b) a concise one-page handout and 4-minute video clip reviewed with the participant and a support individual (family/friend) prior to discharge.

Eligibility criteria

Qualifiers

None

Disqualifiers

Patient has previously received the standard naloxone kit education or has a known allergy to naloxone and/or kit constituents

Patient or support network does not speak English

Patient is in police custody

Patient is not being discharged home from the ED.

Trial design

Treatments tested in this trial

  • Enhanced Overdose Education (EOE)
  • Standard education

Treatment groups

84 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hartford Hospital

Lead sponsor

Hartford HealthCare

Collaborator